VitaNova Life Sciences VNOV
OTC VNOV
$2.50 +0.00 (+0.00%)
At close: Oct 14, 2026 · 4:00 PM EDT

VitaNova Life Sciences (VNOV) EBITDA Margin (2017)

Updated

VitaNova Life Sciences' EBITDA Margin was 117.13% in fiscal Q2 2018 (quarter ended Jul 31, 2017).

Analysis

VitaNova Life Sciences (VNOV) EBITDA Margin (2017) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Accenture 147.34 Bn 106.62 Bn 6.13 Bn 20.09%
2 Cintas 87.13 Bn 86.21 Bn 1.55 Bn 27.84%
3 Iron Mountain 33.97 Bn 33.16 Bn 1.07 Bn 32.67%
4 APi 17.51 Bn 14.55 Bn 703.00 Mn 11.71%
5 Rollins 16.11 Bn 15.65 Bn 569.95 Mn 21.79%
6 UL Solutions 15.12 Bn 13.88 Bn 417.00 Mn 24.02%
7 Aramark 14.68 Bn 12.62 Bn 430.34 Mn 6.95%
8 Gartner 14.60 Bn 8.29 Bn 1.19 Bn 25.36%
9 Rentokil Initial 10.70 Bn 4.21 Bn - -
10 VitaNova Life Sciences 20.84 Mn 15.21 Mn 30,521.00 -
Historic Data

Historic Data

Download Data
DateValue
Jul 31, 2017 117.13%
API Access

VitaNova Life Sciences EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=VNOV&period=max&api_key=YOUR_API_KEY